PopVax RNA Foundry
Hyderabad facility making individualised mRNA cancer vaccines and offering contract R&D and manufacturing
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
The RNA Foundry is PopVax's integrated R&D and GMP-capable clinical dose production facility in Hyderabad, India. Launched for personalised cancer vaccine manufacturing on October 30, 2026, it provides contract research, development and manufacturing services for individualised mRNA cancer vaccines in collaboration with Stochastic Sciences, using tumour sequencing and neoantigen ranking to produce a vaccine for each patient.
- Website
- popvax.com/foundry
- Added via
- web
- Ownership
- unclaimed
Where to go
Product details
- Product kind
- Service